Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women, affecting approximately 10 percent of women worldwide. Its relationship with weight is bidirectional and self-reinforcing in ways that make standard weight loss advice largely ineffective for many women with PCOS: PCOS causes insulin resistance that promotes fat storage, impairs weight loss, and drives carbohydrate cravings; excess weight worsens insulin resistance and increases androgen production from adipose tissue, which in turn worsens the PCOS hormonal picture.
The consequence is that women with PCOS who are told to “just eat less and exercise more” experience significantly poorer results than women without PCOS on the same approach — not because they are less adherent, but because the metabolic driver of their weight is not being addressed. Effective PCOS weight management treats the insulin resistance that is driving the weight gain alongside the lifestyle measures that support weight loss.
Insulin Resistance — The Central Mechanism
Approximately 70 to 80 percent of women with PCOS have insulin resistance — a state in which insulin is produced in normal or elevated amounts but peripheral tissues are less responsive to its effects. The pancreas compensates by producing more insulin (hyperinsulinemia), and the elevated insulin levels directly stimulate ovarian androgen production (worsening the PCOS hormonal picture), promote fat storage particularly in the abdominal region, inhibit fat breakdown, and drive carbohydrate cravings through their effect on blood sugar regulation. The result is a metabolic environment that strongly favors fat gain and resists fat loss regardless of caloric intake.
Hyperandrogenism and Body Composition
Elevated androgens in PCOS produce a body composition pattern that resembles male-pattern fat distribution — central (abdominal) fat accumulation rather than the peripheral (hip and thigh) fat distribution typical of estrogen-dominant female physiology. This central adiposity is not only more cosmetically distressing to many women but also more metabolically dangerous, contributing to the elevated cardiovascular risk of PCOS.
Appetite Dysregulation
Women with PCOS have altered leptin and ghrelin signaling — the hormones that regulate hunger and satiety. Leptin resistance (reduced sensitivity to the satiety signal) and altered ghrelin patterns (heightened hunger signaling) mean that women with PCOS may experience persistent hunger and reduced satiety even when caloric intake is adequate. This is a physiological phenomenon, not a behavioral one, and it is not corrected by willpower alone.
Why 5 to 10 Percent Weight Loss Is Clinically Significant in PCOS
Research consistently shows that even modest weight loss — 5 to 10 percent of body weight — in overweight women with PCOS produces significant improvements in insulin resistance, menstrual regularity, ovulation frequency, androgen levels, and fertility. The metabolic improvement from modest weight loss in PCOS is disproportionately large relative to the weight lost because it directly reduces the insulin resistance that is driving the hormonal and reproductive dysfunction. This is clinically important: the target in PCOS weight management is metabolic improvement, not a specific scale number, and that improvement begins at a level of weight loss that is achievable for most women with appropriate support.
Insulin Sensitization
Metformin is the most widely used insulin-sensitizing medication in PCOS and directly addresses the primary metabolic driver of PCOS-related weight gain. It reduces hepatic glucose production, improves peripheral insulin sensitivity, lowers circulating insulin levels, and in many women reduces carbohydrate cravings and supports modest weight loss. GLP-1 receptor agonists (semaglutide, liraglutide) provide more substantial weight loss alongside insulin sensitization and are increasingly used in PCOS with significant metabolic features.
Low Glycemic Index Diet
Reducing dietary glycemic load — limiting refined carbohydrates, added sugars, and high glycemic index foods while prioritizing protein, fiber, and healthy fats — directly targets insulin resistance by reducing the insulin spikes that drive fat storage and carbohydrate cravings. A low glycemic diet is more specifically effective for PCOS than a general calorie-restriction approach and produces better hormonal and metabolic outcomes for the same degree of weight change.
Combined Oral Contraceptives
Combined oral contraceptives manage the androgenic and menstrual aspects of PCOS — reducing androgen levels, regulating cycles, and in some formulations specifically targeting the androgenic features (acne, hirsutism) with anti-androgenic progestins. They do not directly treat insulin resistance but address the hormonal component of PCOS that contributes to body composition changes, and for women who need both contraception and PCOS management, they serve both purposes.
Our team at Lapeer Women’s Health addresses the metabolic driver of PCOS-related weight. No referral required.
Schedule a Gynecologic VisitEducational purposes only. Not medical advice. Content reviewed by Dr. Ramona D. Andrei, MD PhD FACOG.
Gynecologic care for women of every age
Lapeer Women’s Health — Rochester Hills
2710 S Rochester Rd, Suite 2
Rochester Hills, MI 48307
Serving patients in Lapeer, Rochester Hills, and surrounding communities throughout Southeast Michigan.